Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated

March 26, 2019 updated by: Cagdas Sahin, Ege University
Patients who hypogastric arteries and/or uterine arteries had been ligated will be evaluated in terms of ovarian reserve markers such as anti-mullerian hormone levels, ovarian volumes, antral follicule count, follicule stimuli hormone and estrogen levels. Investigators will search their archives for finding suitable patients for study. Investigators will especially notice being at least 6 month time of interval between surgery and evaluation time. Ultrasound examination and taking blood sample will be performed on 2nd or 3th day of menstrual cycle. These results will be compared with normal postpartum women's results. It will be evaluated that there is or not any effect of the hypogastric arteries and/or uterine arteries on ovarian reserve

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Izmir, Turkey, 35100
        • Recruiting
        • Ege University, Medicine Faculty, Department of Obstetrics and Gynecology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients had been ligated hypogastric and/or uterine arteries
  • Patients are in 6 month period after surgery
  • Without performed hysterectomy
  • No older than 40 years old
  • No history about endocrinopathy which have an effect upon ovarian reserve

Exclusion Criteria:

  • Patients had been made other gynecologic surgery such as fallopian tube ligation and hysterectomy etc.
  • Patients are older than 40 years old
  • Patients use drugs which have an effect upon ovarian reserve
  • Patients have diseases which have an effect upon ovarian reserve such as some endocrinopathy, malign diseases which require radiotherapy and chemotherapy etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypogastric and/or uterine artery ligation
Patients who had been ligated hypogastric artery and or uterine artery for ceasing uterine bleeding during c-section
Procedure: Hypogastric and/or uterine artery ligation
No Intervention: Normal postpartum women

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Anti-mullerian hormone levels will be evaluated
Time Frame: 6 months after surgery and delivery
6 months after surgery and delivery
Antral Follicule Count will be evaluated
Time Frame: 6 months after surgery and delivery
6 months after surgery and delivery
Ovarian volume will be evaluated
Time Frame: 6 months after surgery and delivery
6 months after surgery and delivery
Follicule Stimuli Hormone levels will be evaluated
Time Frame: 6 months after surgery and delivery
6 months after surgery and delivery
Estrogen levels will be evaluated
Time Frame: 6 months after surgery and delivery
6 months after surgery and delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ege University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (Anticipated)

August 1, 2019

Study Completion (Anticipated)

September 1, 2019

Study Registration Dates

First Submitted

December 12, 2016

First Submitted That Met QC Criteria

December 13, 2016

First Posted (Estimate)

December 16, 2016

Study Record Updates

Last Update Posted (Actual)

March 28, 2019

Last Update Submitted That Met QC Criteria

March 26, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2.100.2014.0076

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ovarian Reserve

Clinical Trials on Hypogastric and/or uterine artery ligation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe